Methotrexate Sodium Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Methotrexate Sodium Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Mar 13, 2023. Reported reason: Demand increase for the drug

Shortage details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0143-9519-10
Dosage Form
Injection
Presentation
Methotrexate, Preservative Free, Injection, 25 mg/1 mL (NDC 0143-9519-10)
Initial Posting
Mar 13, 2023

Reason

Demand increase for the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.